Cumulative risk of a second malignant neoplasms (SMN) by risk group for patients not receiving a transplant in first remission (SR: standard risk 2.4% ± 0.7%; IR: intermediate risk 1.2% ± 0.7%; HR: higher risk 0.3% ± 0.3%; P = .007). See the complete figure in the article beginning on page 6077.